Nicholas Alp, M.D., PhD, FACC
Chief Medical Officer
Nicholas has more than 30 years of clinical research experience as an academic cardiologist, clinical trialist, and commercial drug development expert. Before joining Clinical ink, he was Senior Vice President and Head of Cardiometabolic Research at Medpace, a global clinical research organization. Previously, Nicholas was Vice President and Global Head of Cardiovascular Drug Development at ICON. He also simultaneously held appointments as a Consultant Interventional Cardiologist at the John Radcliffe Hospital, Oxford and a senior academic appointment in Cardiovascular Medicine at Oxford University.
Nicholas trained in medicine at London University and Oxford University, completed a PhD in Immunology at Cambridge University, with a further post-doctoral DM degree in Cardiology at Oxford University. He has also contributed to more than 70 peer-reviewed publications and books.
